Your browser doesn't support javascript.
loading
Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group.
Suwannaying, Kunanya; Monsereenusorn, Chalinee; Rujkijyanont, Piya; Techavichit, Piti; Phuakpet, Kamon; Pongphitcha, Pongpak; Chainansamit, Su-On; Chotsampancharoen, Thirachit; Winaichatsak, Angkana; Traivaree, Chanchai; Sathitsamitphong, Lalita; Kanjanapongkul, Somjai; Komvilaisak, Patcharee; Sanpakit, Kleebsabai; Photia, Apichat; Seksarn, Panya; Wiangnon, Surapon; Hongeng, Suradej.
Afiliación
  • Suwannaying K; Division of Hematology-Oncology, Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Monsereenusorn C; Division of Hematology/Oncology, Department of Pediatrics, Phramongkutklao Hospital and Phramongkutklao College of Medicine, Bangkok, Thailand.
  • Rujkijyanont P; Division of Hematology/Oncology, Department of Pediatrics, Phramongkutklao Hospital and Phramongkutklao College of Medicine, Bangkok, Thailand.
  • Techavichit P; Integrative and Innovative Hematology/Oncology Research Unit, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Phuakpet K; Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Pongphitcha P; Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
  • Chainansamit SO; Department of Pediatrics, Khon Kaen Hospital, Khon Kaen, Thailand.
  • Chotsampancharoen T; Department of Pediatrics, Prince of Songkla University, Hat Yai, Songkhla, Thailand.
  • Winaichatsak A; Department of Pediatrics, Maharat Nakhon Ratchasima Hospital, Nakhon Ratchasima, Thailand.
  • Traivaree C; Division of Hematology/Oncology, Department of Pediatrics, Phramongkutklao Hospital and Phramongkutklao College of Medicine, Bangkok, Thailand.
  • Sathitsamitphong L; Department of Pediatrics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
  • Kanjanapongkul S; Division of Hematology-Oncology, Queen Sirikit National Institute of Child Health, Bangkok, Thailand.
  • Komvilaisak P; Division of Hematology-Oncology, Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
  • Sanpakit K; Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.
  • Photia A; Division of Hematology/Oncology, Department of Pediatrics, Phramongkutklao Hospital and Phramongkutklao College of Medicine, Bangkok, Thailand.
  • Seksarn P; Integrative and Innovative Hematology/Oncology Research Unit, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Wiangnon S; Faculty of Medicine, Mahasarakham University, Mahasarakham, Thailand.
  • Hongeng S; Department of Pediatrics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Pediatr Blood Cancer ; 69(9): e29757, 2022 09.
Article en En | MEDLINE | ID: mdl-35560972

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Recurrencia Local de Neoplasia / Neuroblastoma Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Asia Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Recurrencia Local de Neoplasia / Neuroblastoma Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies País/Región como asunto: Asia Idioma: En Revista: Pediatr Blood Cancer Asunto de la revista: HEMATOLOGIA / NEOPLASIAS / PEDIATRIA Año: 2022 Tipo del documento: Article